KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,766,083 | -20.5% | 797,008 | +1.9% | 53.75% | -3.8% |
| Q2 2023 | $169,578,435 | +19.4% | 782,008 | 0.0% | 55.90% | -4.4% |
| Q1 2023 | $142,043,933 | -5.6% | 782,008 | +2.1% | 58.49% | -10.6% |
| Q4 2022 | $150,498,368 | -12.6% | 765,895 | 0.0% | 65.45% | +4.0% |
| Q3 2022 | $172,273,000 | +54.5% | 765,895 | -13.1% | 62.95% | +12.1% |
| Q2 2022 | $111,513,000 | +3.1% | 881,458 | +3.4% | 56.18% | +9.8% |
| Q1 2022 | $108,115,000 | -3.2% | 852,708 | 0.0% | 51.15% | +9.5% |
| Q4 2021 | $111,705,000 | +7.1% | 852,708 | 0.0% | 46.71% | +26.7% |
| Q3 2021 | $104,312,000 | +7.3% | 852,708 | 0.0% | 36.87% | -3.8% |
| Q2 2021 | $97,200,000 | -11.0% | 852,708 | -6.2% | 38.31% | +9.3% |
| Q1 2021 | $109,254,000 | -0.7% | 908,708 | -16.1% | 35.05% | -3.4% |
| Q4 2020 | $110,057,000 | – | 1,083,344 | – | 36.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |